KarXT for Schizophrenia: Mechanism of Action?

Описание к видео KarXT for Schizophrenia: Mechanism of Action?

Introducing KarXT: A New Paradigm

JAMA Psychiatry recently published (on May 1, 2024) the positive results of EMERGENT-3 trials for this potential non-dopaminergic medication for schizophrenia. 

KarXT is a combination of two drugs: xanomeline and trospium chloride. This innovative therapy represents a significant departure from traditional antipsychotic treatments.

Read detailed post here: https://psychiatryeducationforum.com/...

Комментарии

Информация по комментариям в разработке